Drugs: Licensing

(asked on 22nd October 2015) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, whether addressing barriers to licensing off-patent, repurposed drugs in an aim of the current Accelerated Access Review.


Answered by
George Freeman Portrait
George Freeman
This question was answered on 27th October 2015

The Accelerated Access Review, chaired by Sir Hugh Taylor, will make recommendations to government on reforms to accelerate access for National Health Service patients to innovative medicines and medical technologies (including devices, diagnostics and digital), making our country the best place in the world to design, develop and deploy these products. This will cover products that may already be on the market and off patent but are being innovatively repurposed to treat conditions other than those in remit of the existing license.

Reticulating Splines